Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.
Sho M, et al.
Langenbecks Arch Surg. 2015 May;400(4):477-85. doi: 10.1007/s00423-015-1304-0. Epub 2015 May 1.
Langenbecks Arch Surg. 2015.
PMID: 25929828